Each pharmaceutical company that does business in this state and that offers a patient assistance program shall inform the commission of:
(1) the existence of the program;
(2) the eligibility requirements for the program;
(3) the drugs covered by the program; and
(4) information used for applying for the program, such as a telephone number.